Cannara Biotech Inc.

TSXV:LOVE.V

0.96 (CAD) • At close March 19, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CAD.

2025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Omzet 26.58625.0723.03619.54519.68319.48318.33115.8413.03610.31211.79110.0647.4226.5656.2357.1592.2581.3680.5850.7640.6680.5330.5530.5070.5180.518
Kosten van de omzet 14.63114.89212.58412.58715.54311.2488.4347.3438.7745.4794.8445.3154.4076.891.9562.740.1630.2851.0460.0480.1980.0340.0480.2210.0820.053
Brutowinst 11.95610.17910.4536.9584.148.2359.8978.4984.2624.8336.9474.7493.016-0.3254.284.4192.0951.083-0.4610.7160.470.50.5050.2860.4370.466
Brutowinstmarge 0.450.4060.4540.3560.210.4230.540.5360.3270.4690.5890.4720.406-0.050.6860.6170.9280.792-0.7880.9370.7030.9370.9130.5640.8420.899
Onderzoek- en ontwikkelingskosten 0.1710.1720.2410.350.320.210.3060.2620.2460.2160.3240.370.3060.2560.230.4430.6830.550.6621.3410.36900000
Algemene en administratieve kosten 03.2642.9473.2513.8952.8792.5042.9392.5222.6452.2062.1112.4691.8042.151.1691.2741.5711.8521.2852.6822.4731.8562.7362.0630.013
Verkoop- en marketingkosten 02.2292.1211.6041.6581.2931.0050.850.5460.5080.4610.3740.3030.30.3220.3110.2430.2650.2440.2610.1850.2160.2640.0350.1920.275
Verkoop-, algemene en administratieve kosten 5.6255.4935.0684.8546.14.1723.5093.7893.0683.1532.6672.4862.7712.1032.4721.481.5171.8362.0961.5462.8672.6892.1192.772.2550.013
Overige kosten 00.2820.099-1.800000.2790.2940.1850.3510.3050.2320.0230.2370.2520.2740.2170.0260.7250.5280.1490.150.1390
Bedrijfskosten 6.0785.9475.4083.4046.14.7913.9964.2153.5933.6643.1763.2063.3822.5922.7252.162.4522.6612.9752.9193.963.2182.2682.9212.3940.013
Bedrijfsresultaat 5.8774.2325.0453.554-1.963.4395.8314.2820.3750.823.7631.162-0.596-0.1441.5672.259-0.411-3.158-3.485-2.259-3.49-2.718-3.638-2.635-1.957-0.013
Bedrijfsresultaat ratio 0.2210.1690.2190.182-0.10.1760.3180.270.0290.080.3190.115-0.08-0.0220.2510.316-0.182-2.308-5.955-2.957-5.221-5.097-6.576-5.2-3.776-0.024
Totaal overige inkomsten en kosten netto -1.148-1.198-1.245-1.531-1.487-1.331-1.2-1.354-1.249-1.14-1.209-0.106-0.773-0.547-0.435-0.562-0.452-0.337-0.424-0.248-0.247-0.223-0.194-0.187-2.054-0.313
Inkomen voor belasting 4.7293.0343.82.023-3.4472.1074.6322.929-0.6180.0032.5531.428-1.146-0.531.1321.698-0.863-3.495-3.909-2.507-3.737-2.941-3.832-2.823-4.012-0.013
Inkomen voor belasting ratio 0.1780.1210.1650.104-0.1750.1080.2530.185-0.04700.2170.142-0.154-0.0810.1820.237-0.382-2.555-6.679-3.282-5.591-5.515-6.926-5.57-7.738-0.024
Belastingkosten 1.4150.728-1.95503.4471.0590.331.1650.024-0.047-0.057-0.660.1760.3960.430.4260.3810.3290.2620.1920.1450.1150.1280.1180.241-0.417
Nettowinst 3.3152.3065.7542.023-3.4472.1074.6322.929-0.6420.0492.5532.089-1.322-0.9271.1321.698-0.863-3.495-3.86-2.375-3.529-2.719-3.577-2.554-3.878-0.013
Nettowinstmarge 0.1250.0920.250.104-0.1750.1080.2530.185-0.0490.0050.2170.208-0.178-0.1410.1820.237-0.382-2.555-6.594-3.109-5.28-5.099-6.465-5.04-7.481-0.024
WPA (Winst Per Aandeel) 0.0370.02600.023-0.0380.0230.0510.033-0.0070.0010.0290.024-0.015-0.0110.0130.1-0.012-0.047-0.001-0.033-0.05-0.039-0.001-0.037-0.066-0
Verwaterde WPA 0.0360.02500.022-0.0380.0230.0510.033-0.0070.0010.0290.024-0.015-0.0110.0130.1-0.012-0.047-0.001-0.033-0.05-0.039-0.001-0.037-0.066-0
EBITDA 7.3365.6385.8415.099-0.9155.117.2435.5921.8972.4564.9893.28-0.2080.6412.4892.9020.285-2.451-2.873-1.549-2.653-2.063-3.292-2.282-3.495-1.804
EBITDA ratio 0.2760.2250.2540.261-0.0460.2620.3950.3530.1460.2380.4230.326-0.0280.0980.3990.4050.126-1.792-4.909-2.028-3.97-3.869-5.95-4.504-6.741-3.48